Mycoplasma Biosafety Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Mycoplasma Biosafety General Information


Provider of GMP-compliant mycoplasma testing and related services and products intended to contribute to the development, production and safety of biological medicinal products. The company offers a comprehensive range of mycoplasma tests by the conventional culture methods and new rapid NAT-based assays, as well as culture media and reference standard products for mycoplasma testing, test and process validations, enabling research laboratories and biotech companies to prepare mycoplasma antigens for serodiagnostic assays.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Primary Office
  • BioTech Center Muthgasse
  • Muthgasse 11/2
  • Vienna, 1190
  • Austria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mycoplasma Biosafety Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2018 00000 Completed Out of Business
2. Equity Crowdfunding 01-Jan-2017 00000 00000 00.000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Mycoplasma Biosafety’s complete valuation and funding history, request access »